MRC Human Nutrition Research, Elsie Widdowson Laboratory, Cambridge CB1 9NL, United Kingdom.
Osteoporos Int. 2013 Mar;24(3):1121-4. doi: 10.1007/s00198-012-2029-3. Epub 2012 May 31.
Fibroblast growth factor 23 (FGF23) is grossly elevated in Gambian children with rickets and, at a lower prevalence, in those without bone deformities. We used western blotting to mimic the detection capabilities of the C-terminal FGF23 enzyme-linked immunosorbent assay (ELISA). Only intact FGF23 hormone was present in Gambian plasma samples from children with and without rickets.
Elevated circulating FGF23 concentrations have been detected in plasma samples from Gambian children using the C-terminal Immutopics ELISA. The Immutopics ELISA detects both the intact FGF23 hormone and the C-terminal fragment. The aim of this study was to determine whether the elevated FGF23 concentrations as detected by the ELISA were predominantly due to a high proportion of intact FGF23 hormone and/or C-terminal FGF23 fragments.
Stored, frozen plasma samples from previous studies of Gambian children with known concentrations of FGF23 as determined by C-terminal Immutopics ELISA assay, were selected for western blotting analysis: from children with rickets-like bone deformities (n = 4) and local controls (n = 4), with elevated >900 RU/ml (n = 2) and normal <30 RU/ml (n = 2; from each group). The anti-FGF23 polyclonal antibody that recognizes the C-terminal of FGF23 (as used in the Immutopics kit) was used as the primary antibody and the anti-IgG polyclonal antibody conjugated to horseradish peroxidase (HRP) was used as the secondary antibody.
Firstly, C-terminal FGF23 fragments, although detectable in standards from the Immutopics ELISA kit, were not in the Gambian plasma samples. Secondly, there was no difference in the size of FGF23 molecules present in plasma from children with rickets-like bone deformities and children from the local community.
Western blotting has provided evidence that elevated FGF23 concentrations, as determined by the C-terminal Immutopics ELISA, measured in Gambian children with and without rickets-like bone deformities was not caused by an increased proportion of circulating inactive C-terminal fragments.
成纤维细胞生长因子 23(FGF23)在冈比亚佝偻病儿童中显著升高,在无骨畸形的儿童中也以较低的患病率升高。我们使用 Western 印迹法模拟 C 端 FGF23 酶联免疫吸附测定(ELISA)的检测能力。有和没有佝偻病的冈比亚儿童血浆样本中仅存在完整的 FGF23 激素。
使用 C 端 Immutopics ELISA 在冈比亚儿童的血浆样本中检测到循环 FGF23 浓度升高。Immutopics ELISA 检测完整的 FGF23 激素和 C 端片段。本研究旨在确定 ELISA 检测到的升高的 FGF23 浓度主要是由于高比例的完整 FGF23 激素和/或 C 端 FGF23 片段。
选择之前已知 FGF23 浓度的冈比亚儿童的冷冻储存血浆样本进行 Western 印迹分析:来自佝偻病样骨畸形的儿童(n = 4)和当地对照(n = 4),浓度升高>900 RU/ml(n = 2)和正常<30 RU/ml(n = 2;来自每个组)。用于 Immutopics 试剂盒的识别 FGF23 C 端的多克隆抗 FGF23 抗体被用作初级抗体,辣根过氧化物酶(HRP)偶联的抗 IgG 多克隆抗体被用作次级抗体。
首先,尽管 Immutopics ELISA 试剂盒的标准品中可检测到 C 端 FGF23 片段,但在冈比亚血浆样本中不存在。其次,佝偻病样骨畸形儿童和当地社区儿童血浆中存在的 FGF23 分子大小无差异。
Western 印迹法提供了证据,表明 C 端 Immutopics ELISA 测定的升高的 FGF23 浓度,在有和没有佝偻病样骨畸形的冈比亚儿童中,不是由循环无活性 C 端片段的比例增加引起的。